Laura Sepp-Lorenzino - Insider Trading & Ownership

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Summary
The estimated net worth of Laura Sepp-Lorenzino is at least $2.86M dollars as of May 31, 2024. Laura Sepp-Lorenzino is the EVP, Chief Scientific Officer of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $2.79M. Laura Sepp-Lorenzino is the Director of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $74.3K.
All Insider Reports
All Insider Reports

Ownership of Laura Sepp-Lorenzino

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTLA Intellia Therapeutics, Inc. EVP, Chief Scientific Officer $2.79M -$229K -7.59% Mar 1, 2024
TSHA Taysha Gene Therapies, Inc. Director $74.3K May 29, 2024

Insider Transactions Reported by Laura Sepp-Lorenzino:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.